Literature DB >> 26067133

Maspin-related Orchestration of Aggressiveness of Gastric Cancer.

Simona Gurzu1, Zoltan Kadar, Haruhiko Sugimura, Janina Orlowska, Tivadar Bara, Tivadar Bara, Janos Szederjesi, Ioan Jung.   

Abstract

BACKGROUND AND STUDY AIM: Although some hypotheses have been postulated on the genesis of gastric cancer (GC), the origin of this disease remains unclear. The aim of this study was to develop a hypothesis about gastric carcinogenesis based on our experience in the field of GC and on published reports on about 28 studies in the field of subcellular maspin expression in GC. In 180 cases of GC, the clinicopathologic features were correlated with the results obtained after paired immunohistochemical stains (tumor/normal mucosa) with 15 antibodies: E-cadherin, HER-2, VEGF, CD31, CD105, COX-2, maspin, bax, bcl-2, p53, Ki67, MLH-1, MSH-2, Mena protein, and vimentin.
RESULTS: Cytoplasmic maspin was observed in foveolar cells with intestinal metaplasia, whereas mixed (combined nuclear-cytoplasmic) expressions were more characteristic of the intramucosal foci of signet-ring cells and dysplastic cells. The tumor cells that expressed cytoplasmic maspin were mostly intestinal type bax/COX-2/Mena/E-cadherin-positive differentiated adenocarcinomas with nodular growth and more superficial invasion. The nuclear shift of maspin was more frequent in HER-2/p53-positive intestinal type adenocarcinomas with diffuse architecture at the invasion front, as well as for node-positive poorly cohesive carcinomas. Loss of maspin expression induced a higher risk of distant metastases, without differences in the survival rate.
CONCLUSIONS: In GC with associated metaplasia, cytoplasmic maspin is predominant; the nuclear shift induces local aggressiveness and risk of node metastases, whereas total loss can indicate a risk of distant metastases. In GC without associated metaplasia, nuclear expression of maspin is retained, indicating a more aggressive behavior.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26067133     DOI: 10.1097/PAI.0000000000000189

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  8 in total

1.  The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients.

Authors:  Ming Lu; Zuyao Yang; Qi Feng; Mei Yu; Yuelun Zhang; Chen Mao; Lin Shen; Jinling Tang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

2.  Immunohistochemical features and staging of early gastric cancer.

Authors:  Simona Gurzu; Janina Orlowska; Haruhiko Sugimura; Tivadar Bara; Zoltan Szentirmay; Wladyslaw Januszewicz; Tivadar Bara; Janos Szederjesi; Ioan Jung
Journal:  Arch Med Sci       Date:  2016-03-22       Impact factor: 3.318

3.  Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: Results from the surveillance, epidemiology, and end results database.

Authors:  Liyuan Zhou; Weihua Li; Shaoxin Cai; Changshun Yang; Yi Liu; Zhizun Lin
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

Review 4.  Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe.

Authors:  Simona Gurzu; Ioan Jung
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

5.  New Insights in Histogenetic Pathways of Gastric Cancer.

Authors:  Simona Gurzu; Haruhiko Sugimura; Janina Orlowska; Zoltan Szentirmay; Ioan Jung
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

6.  Unexpected maspin immunoreactivity in Merkel cell carcinoma.

Authors:  Sabin Gligore Turdean; Simona Gurzu; Ioan Jung; Radu Mircea Neagoe; Daniela Sala
Journal:  Diagn Pathol       Date:  2015-11-25       Impact factor: 2.644

7.  The roles of maspin expression in gastric cancer: a meta- and bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Bao-Cheng Gong
Journal:  Oncotarget       Date:  2017-08-11

8.  Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer.

Authors:  Di Chen; Li Xu; Xiaowei Li; Yi Chu; Mingzuo Jiang; Bing Xu; Min Zhao; Weijie Wang; Hua Wang; Huijie Kang; Kai Wang; Kaichun Wu; Jie Liang; Gui Ren
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.